Advances in the treatment of neovascular age-related macular degeneration

被引：0
|
作者：
Lanzetta, Paolo [1 ]
机构：
[1] Univ Udine, Dept Ophthalmol, I-33100 Udine, Italy
来源：
EJHP PRACTICE | 2008年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The management of age-related macular degeneration has rapidly progressed following the development of the anti-vascular endothelial growth factor (VEGF) ranibizumab. Ongoing trials are helping to define appropriate treatment schedules to optimise the use of ranibizumab in clinical practice.
引用
收藏
页码：17 / 20
页数：4
相关论文
共 50 条
  • [41] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    PHARMACEUTICS, 2023, 15 (05)
  • [42] Pharmacological Advances in the Treatment of Age-related Macular Degeneration
    Gil-Martinez, Maria
    Santos-Ramos, Paz
    Fernandez-Rodriguez, Maribel
    Abraldes, Maximino J.
    Jose Rodriguez-Cid, Maria
    Santiago-Varela, Maria
    Fernandez-Ferreiro, Anxo
    Gomez-Ulla, Francisco
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (04) : 583 - 598
  • [43] Macular atrophy development in neovascular age-related macular degeneration
    Calugaru, Dan
    Calugaru, Mihai
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) : NP307 - NP308
  • [44] Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
    Sivaprasad, Sobha
    CLINICAL OPHTHALMOLOGY, 2008, 2 (02): : 339 - 346
  • [45] Targeting BMP signalling for the treatment of neovascular age-related macular degeneration
    Ntumba, Kalonji
    Eichmann, Anne
    Larrivee, Bruno
    ANGIOGENESIS, 2014, 17 (04) : 938 - 939
  • [46] Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, H
    Schiller, DS
    CLINICAL THERAPEUTICS, 2006, 28 (01) : 36 - 44
  • [47] Treatment of age-related neovascular macular degeneration: the patient's perspective
    Mueller, S.
    Ehlken, C.
    Bauer-Steinhusen, U.
    Lechtenfeld, W.
    Hasanbasic, Z.
    Agostini, H.
    Wilke, T.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (11) : 2237 - 2246
  • [48] Intravitreal bevacizumab (avastin) treatment of neovascular age-related macular degeneration
    Emerson, M. Vaughn
    Lauer, Andreas K.
    Flaxel, Christina J.
    Wilson, David J.
    Francis, Peter J.
    Stout, J. Timothy
    Emerson, Geoffrey G.
    Schlesinger, Thomas K.
    Nolte, Susan K.
    Klein, Michael L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 439 - 444
  • [49] Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
    Yannuzzi, Nicolas A.
    Freund, K. Bailey
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1323 - 1329
  • [50] Pharmacogenetic Studies of Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Den Hollander, A. I.
    Smailhodzic, D.
    Khan, H. A.
    Omar, A.
    Zhang, A. Y.
    Kirchhof, B.
    Chen, J.
    Hoyng, C. B.
    Koenekoop, R. K.
    Fauser, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345